Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OraSure License/Marketing Pact With Abbott To Aid OraQuick HIV Test Launch

This article was originally published in The Gray Sheet

Executive Summary

OraSure Technologies' license of non-exclusive rights to certain test strip technology patents from Abbott appears to clear the way for a U.S. launch of OraSure's OraQuick rapid HIV-1 test, pending FDA approval

You may also be interested in...



Litigation In Brief

J&J/Medtronic stent litigation: Supreme Court declines to review ruling awarding Johnson & Johnson/Cordis $271 mil. for infringement of stent patents, including those related to its Palmaz-Schatz('762), denying a writ of certiorari in the case. The U.S. Court of Appeals for the Federal Circuit had denied a rehearing in September 2003 after siding with J&J last August and remanded the case back to its original Wilmington, Del. district court (1"The Gray Sheet" Oct. 6, 2003, In Brief). Medtronic notes that the stents at issue are obsolete...

Litigation In Brief

J&J/Medtronic stent litigation: Supreme Court declines to review ruling awarding Johnson & Johnson/Cordis $271 mil. for infringement of stent patents, including those related to its Palmaz-Schatz('762), denying a writ of certiorari in the case. The U.S. Court of Appeals for the Federal Circuit had denied a rehearing in September 2003 after siding with J&J last August and remanded the case back to its original Wilmington, Del. district court (1"The Gray Sheet" Oct. 6, 2003, In Brief). Medtronic notes that the stents at issue are obsolete...

Rapid HIV-1 tests

CLIA-waived status for the tests is being pursued by an HIV coalition supported by the President's Advisory Council on HIV/AIDS and the Congressional Black Caucus. "We call on [FDA and CMS] to release HIV rapid tests with CLIA waiver immediately," the groups state in an Oct. 24 release, arguing that state regulations provide sufficient safeguards. OraSure received a May "approvable" letter from FDA for its OraQuick rapid HIV test, requiring resolution of "specific validation and control issues" before agency sign-off (1"The Gray Sheet" June 24, 2002, p. 22)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016776

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel